Prader-Willi syndrome is a rare genetic disease that causes poor feeding in infancy but later triggers insatiable hunger.

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...

Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for central nervous system and oncology-related conditions. Its lead candidates, NDV-01 ...

Prader-Willi syndrome: MIM#176270); 22q11.21 (n=16, DiGeorge syndrome: MIM#188400); 7q11.23 (n=9, Williams-Beuren syndrome: MIM#194050; chromosome 7q11.23 duplication syndrome: MIM#609757). Diagnosed ...

Details of the presentations are as follows: The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The hallmark symptom of this disorder is ...

Environmental factors such as lifestyle and the medications you take influence the effects your genes have on your body − and ...

The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The hallmark symptom of this disorder is hyperphagia, a chronic and life-threatening condition ...

Using a method known as genome-wide association studies, the researchers scanned genomes to identify genes driving OCD.

This study presents a valuable meta-analysis of two independent genome-wide association studies (GWASs) elucidating the role of plasma proteins as biomarkers for improving early detection of prostate ...

Delayed lactogenesis II denotes a longer than usual interval between the colostrum phase and copious milk production, but whereby the mother has the ability to achieve full lactation. Failed ...